<DOC>
	<DOCNO>NCT01728870</DOCNO>
	<brief_summary>The purpose study assess efficacy tolerability novel dietary intervention early CD base partial enteral nutrition , compare gold standard difficult implement dietary intervention- Exclusive enteral nutrition Modulen .</brief_summary>
	<brief_title>Partial Enteral Nutrition With Unique Diet v . Exclusive Enteral Nutrition Treatment Pediatric Crohn 's Disease</brief_title>
	<detailed_description>Background : Crohn 's disease clearly rise country expose industrialization western diet . Several factor may implicate diet pathogenesis CD disease activity . The strong argument effect diet effect exclusive enteral nutrition ( EEN ) disease activity CD . 40-80 % child , feed exclusive liquid diet , irrespective diet , enter complete remission , often normalization inflammatory marker . The effect formula show independent fat protein composition pediatric study , dependent exclusion normal diet.Thus , rather composition EEN associate remission disease may exclusion certain component Western diet may responsible improvement . Methods : This prospective randomized control trial , patient recent diagnosis CD ( two year ) , age 4-18 , compare two arm 12 week therapy . Group 1 : receive 50 % dietary need polymeric formula ( Modulen , Nestle ) limit whole food diet 6 weeks/ Group 2 : receive EEN Modulen 6 week . At end 6 week , patient enter remission ( irrespective randomization ) enter second 6 week phase , continue 25 % calorie Modulen group . Patients remission group 2 continue consume 25 % calorie Modulen allow free diet , patient Group 1 continue 25 % calorie Modulen continue restrict diet . Patients see onset ( week 0 ) , week 3 6 , 12 24 week . We hypothesize withdraw offend dietary agent achieve equal remission rate improve tolerability . This study evaluate response , remission tolerability group , well effect nutrition bone health .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1 . Children 418 year age . 2 . Patients diagnosis CDduration disease 36 month 3 . Have macroscopic small bowel involvement , isolate large bowel disease confine right transverse colon 4 . Patients pediatric activity index PCDAI ≥ 10 5 . Patients exclude receive 5ASA immunomodulator &gt; 8 week dose stable , start thiopurine concurrently , thiopurines consider sufficient induce remission active disease 8 week isolated therapy . 6 . Informed Consent 1 . Patients disease activity ( PCDAI &lt; 10 ) severe disease ( PCDAI ≥ 40 ) . 2 . Patients receive corticosteroid kind previous 4 week . 3 . Patients start immunomodulator previous 8 week 4 . Any current biological treatment 5 . Isolated Large bowel disease ( L2 ) involve rectosigmoid descend colon 6 . Patients penetrate disease ( abscess fistula ) 7 . Active Perianal disease 8 . Fixed stricture small bowel obstruction 9 . Normal CRP ESR 10 . Active joint disease . 11 . Patients undergone intestinal resection . 12 . Sclerosing Cholangitis 13 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>Mild moderate Crohn 's Disease</keyword>
	<keyword>Diet</keyword>
	<keyword>Enteral Nutrition</keyword>
</DOC>